SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-19-012723
Filing Date
2019-03-07
Accepted
2019-03-07 13:12:08
Documents
54
Period of Report
2018-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tv515343_10k.htm 10-K 637064
2 EXHIBIT 31 tv515343_ex31.htm EX-31 11461
3 EXHIBIT 32 tv515343_ex32.htm EX-32 4766
  Complete submission text file 0001144204-19-012723.txt   2321802

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT qbio-20181130.xml EX-101.INS 297300
5 XBRL TAXONOMY EXTENSION SCHEMA qbio-20181130.xsd EX-101.SCH 27187
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qbio-20181130_cal.xml EX-101.CAL 35162
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qbio-20181130_def.xml EX-101.DEF 53660
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE qbio-20181130_lab.xml EX-101.LAB 173171
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qbio-20181130_pre.xml EX-101.PRE 140324
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-K | Act: 34 | File No.: 000-55535 | Film No.: 19665192
SIC: 2834 Pharmaceutical Preparations